日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?

伴有 H3 p.K28M(K27M)突变的弥漫性半球神经胶质瘤:弥漫性中线神经胶质瘤是否出现异常非中线表现,H3 K27M 改变?

Kliment Donev, Vanitha Sundararajan, Derek Johnson, Jagadheshwar Balan, Meagan Chambers, Vera A Paulson, Kathryn P Scherpelz, Zied Abdullaev, Martha Quezado, Patrick J Cimino, Drew Pratt, Ediel Valerio, João Vıctor Alves de Castro, Dirce Maria Carraro, Giovana Tardin Torrezan, Beatriz Martins Wolff,

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

ONC201治疗H3K27M突变型弥漫性中线胶质瘤的临床疗效是由整合代谢和表观遗传通路紊乱驱动的

Sriram Venneti # ,Abed Rahman Kawakibi # ,Sunjong Ji # ,Sebastian M Waszak # ,Stefan R Sweha # ,Mateus Mota # ,Matthew Pun # ,Akash Deogharkar ,Chan Chung ,Rohinton S Tarapore ,Samuel Ramage ,Andrew Chi ,Patrick Y Wen ,Isabel Arrillaga-Romany ,Tracy T Batchelor ,Nicholas A Butowski ,Ashley Sumrall ,Nicole Shonka ,Rebecca A Harrison ,John de Groot ,Minesh Mehta ,Matthew D Hall ,Doured Daghistani ,Timothy F Cloughesy ,Benjamin M Ellingson ,Kevin Beccaria ,Pascale Varlet ,Michelle M Kim ,Yoshie Umemura ,Hugh Garton ,Andrea Franson ,Jonathan Schwartz ,Rajan Jain ,Maureen Kachman ,Heidi Baum ,Charles F Burant ,Sophie L Mottl ,Rodrigo T Cartaxo ,Vishal John ,Dana Messinger ,Tingting Qin ,Erik Peterson ,Peter Sajjakulnukit ,Karthik Ravi ,Alyssa Waugh ,Dustin Walling ,Yujie Ding ,Ziyun Xia ,Anna Schwendeman ,Debra Hawes ,Fusheng Yang ,Alexander R Judkins ,Daniel Wahl ,Costas A Lyssiotis ,Daniel de la Nava ,Marta M Alonso ,Augustine Eze ,Jasper Spitzer ,Susanne V Schmidt ,Ryan J Duchatel ,Matthew D Dun ,Jason E Cain ,Li Jiang ,Sylwia A Stopka ,Gerard Baquer ,Michael S Regan ,Mariella G Filbin ,Nathalie Y R Agar ,Lili Zhao ,Chandan Kumar-Sinha ,Rajen Mody ,Arul Chinnaiyan ,Ryo Kurokawa ,Drew Pratt ,Viveka N Yadav ,Jacques Grill ,Cassie Kline ,Sabine Mueller ,Adam Resnick ,Javad Nazarian ,Joshua E Allen ,Yazmin Odia ,Sharon L Gardner ,Carl Koschmann

Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma

空间上不同的 THY1 阳性细胞的亚克隆进化和扩增与胶质母细胞瘤复发相关

Wajd N Al-Holou, Hanxiao Wang, Visweswaran Ravikumar, Sunita Shankar, Morgan Oneka, Ziad Fehmi, Roel Gw Verhaak, Hoon Kim, Drew Pratt, Sandra Camelo-Piragua, Corey Speers, Daniel R Wahl, Todd Hollon, Oren Sagher, Jason A Heth, Karin M Muraszko, Theodore S Lawrence, Ana C de Carvalho, Tom Mikkelsen, 

Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1

多平台分子分析完善了 1 型神经纤维瘤病患者所患的神经胶质瘤的分类

Calixto-Hope G Lucas, Emily A Sloan, Rohit Gupta, Jasper Wu, Drew Pratt, Harish N Vasudevan, Ajay Ravindranathan, Jairo Barreto, Erik A Williams, Anny Shai, Nicholas S Whipple, Carol S Bruggers, Ossama Maher, Burt Nabors, Michael Rodriguez, David Samuel, Melandee Brown, Jason Carmichael, Rufei Lu, K

ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization

胶质瘤中的 ATRX 缺失导致细胞周期相变失调和 ATM 抑制剂放射增敏

Tingting Qin, Brendan Mullan, Ramya Ravindran, Dana Messinger, Ruby Siada, Jessica R Cummings, Micah Harris, Ashwath Muruganand, Kalyani Pyaram, Zachary Miklja, Mary Reiber, Taylor Garcia, Dustin Tran, Carla Danussi, Jacqueline Brosnan-Cashman, Drew Pratt, Xinyi Zhao, Alnawaz Rehemtulla, Maureen A S

Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma

病毒状态可预测默克尔细胞癌的基因组甲基化模式和地西他滨反应

Paul W Harms, Monique E Verhaegen, Josh N Vo, Jean C Tien, Drew Pratt, Fengyun Su, Saravana M Dhanasekaran, Xuhong Cao, Doris Mangelberger, Julia VanGoor, Jae Eun Choi, Vincent T Ma, Andrzej A Dlugosz, Arul M Chinnaiyan

Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas

弥漫性内生性脑桥胶质瘤中H3K27M突变介导的代谢和表观基因组整合重编程

Chan Chung ,Stefan R Sweha ,Drew Pratt ,Benita Tamrazi ,Pooja Panwalkar ,Adam Banda ,Jill Bayliss ,Debra Hawes ,Fusheng Yang ,Ho-Joon Lee ,Mengrou Shan ,Marcin Cieslik ,Tingting Qin ,Christian K Werner ,Daniel R Wahl ,Costas A Lyssiotis ,Zhiguo Bian ,J Brad Shotwell ,Viveka Nand Yadav ,Carl Koschmann ,Arul M Chinnaiyan ,Stefan Blüml ,Alexander R Judkins ,Sriram Venneti

SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors

SWI/SNF 复合物异质性与横纹肌瘤的多表型分化、预后和免疫反应相关

Pooja Panwalkar, Drew Pratt, Chan Chung, Derek Dang, Paul Le, Daniel Martinez, Jill M Bayliss, Kyle S Smith, Mike Adam, Steven Potter, Paul A Northcott, Leo Mascarenhas, Jared Shows, Bruce Pawel, Ashley Margol, Annie Huang, Alexander R Judkins, Sriram Venneti0

Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma

程序性死亡配体 1 是复发性异柠檬酸脱氢酶野生型胶质母细胞瘤的负面预后标志物

Drew Pratt, Gifty Dominah, Graham Lobel, Arnold Obungu, John Lynes, Victoria Sanchez, Nicholas Adamstein, Xiang Wang, Nancy A Edwards, Tianxia Wu, Dragan Maric, Amber J Giles, Mark R Gilbert, Martha Quezado, Edjah K Nduom

Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry

髓母细胞瘤治疗会产生预后不良的 H3 野生型弥漫性内在性脑桥胶质瘤亚组的风险:国际 DIPG 登记处的一份报告

Hunter C Gits, Maia Anderson, Stefanie Stallard, Drew Pratt, Becky Zon, Christopher Howell, Chandan Kumar-Sinha, Pankaj Vats, Katayoon Kasaian, Daniel Polan, Martha Matuszak, Daniel E Spratt, Marcia Leonard, Tingting Qin, Lili Zhao, James Leach, Brooklyn Chaney, Nancy Yanez Escorza, Jacob Hendershot